Though it is still unclear whether the A3 receptor is involved in MS, this receptor has been demonstrated to mediate the inhibition of TNF-α production by adenosine (Lee et al., 2006; Levy et al., 2006). This evidence concerns the gene TNF and myeloid sarcoma.